Free Trial

Ucommune International (UK) Competitors

Ucommune International logo
$1.00 -0.01 (-1.00%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$0.95 -0.05 (-5.09%)
As of 08/15/2025 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UK vs. RVYL, LICN, DKDCA, BINI, SRAX, TC, VCIG, APDN, AUUD, and HAO

Should you be buying Ucommune International stock or one of its competitors? The main competitors of Ucommune International include Ryvyl (RVYL), Lichen International (LICN), Data Knights Acquisition (DKDCA), Bollinger Innovations (BINI), SRAX (SRAX), Token Cat (TC), VCI Global (VCIG), Applied DNA Sciences (APDN), Auddia (AUUD), and Haoxi Health Technology (HAO). These companies are all part of the "business services" industry.

Ucommune International vs. Its Competitors

Ryvyl (NASDAQ:RVYL) and Ucommune International (NASDAQ:UK) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Ucommune International has a net margin of 0.00% compared to Ryvyl's net margin of -49.47%. Ucommune International's return on equity of 0.00% beat Ryvyl's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryvyl-49.47% -655.77% -14.58%
Ucommune International N/A N/A N/A

In the previous week, Ryvyl had 4 more articles in the media than Ucommune International. MarketBeat recorded 6 mentions for Ryvyl and 2 mentions for Ucommune International. Ucommune International's average media sentiment score of 0.93 beat Ryvyl's score of 0.42 indicating that Ucommune International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryvyl
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ucommune International
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ucommune International has lower revenue, but higher earnings than Ryvyl.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryvyl$56M0.04-$26.83M-$8.52-0.03
Ucommune International$23.92M0.03-$9.49MN/AN/A

17.4% of Ryvyl shares are held by institutional investors. Comparatively, 36.9% of Ucommune International shares are held by institutional investors. 30.8% of Ryvyl shares are held by insiders. Comparatively, 14.2% of Ucommune International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryvyl
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ucommune International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Ryvyl has a beta of 3.55, meaning that its stock price is 255% more volatile than the S&P 500. Comparatively, Ucommune International has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500.

Summary

Ryvyl and Ucommune International tied by winning 6 of the 12 factors compared between the two stocks.

Get Ucommune International News Delivered to You Automatically

Sign up to receive the latest news and ratings for UK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UK vs. The Competition

MetricUcommune InternationalREAL ESTATE OPS IndustryFinance SectorNASDAQ Exchange
Market Cap$630K$6.57B$12.44B$9.82B
Dividend YieldN/A4.05%5.55%4.08%
P/E RatioN/A22.9819.6225.12
Price / Sales0.036.6425.74116.51
Price / CashN/A22.0721.8559.05
Price / Book0.031.882.286.18
Net Income-$9.49M$105.94M$1.00B$264.89M
7 Day Performance-1.97%2.17%1.23%4.22%
1 Month Performance-6.55%1.33%1.37%2.02%
1 Year Performance-38.66%20.02%539.14%24.22%

Ucommune International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UK
Ucommune International
0.7951 of 5 stars
$1.00
-1.0%
N/A-39.0%$630K$23.92M0.00510
RVYL
Ryvyl
1.6451 of 5 stars
$0.30
-7.9%
N/A-77.5%$2.52M$56M-0.0450News Coverage
Short Interest ↓
Gap Down
LICN
Lichen International
N/A$4.12
-4.4%
N/A-98.9%$2.46M$41.48M0.00390Positive News
Gap Down
DKDCA
Data Knights Acquisition
N/A$0.47
-3.7%
N/A-26.3%$2.43MN/A-2.472Gap Down
High Trading Volume
BINI
Bollinger Innovations
N/A$1.38
-8.2%
N/A-100.0%$2.40M$1.09M0.00120Earnings Report
Gap Down
High Trading Volume
SRAX
SRAX
N/A$0.08
+52.2%
N/AN/A$2.22M$29.29M0.00130Gap Down
TC
Token Cat
N/A$0.67
-8.5%
N/A-68.5%$2.12M$6.74M0.00620Positive News
Gap Down
VCIG
VCI Global
0.4799 of 5 stars
$0.90
+3.7%
N/A-99.6%$1.88M$27.83M0.00102News Coverage
Short Interest ↑
APDN
Applied DNA Sciences
0.2577 of 5 stars
$4.10
-3.5%
N/A-98.8%$1.80M$3.43M-0.0170News Coverage
Negative News
Earnings Report
Short Interest ↑
AUUD
Auddia
0.5779 of 5 stars
$2.65
-13.0%
N/A-86.0%$1.75MN/A-0.0920Earnings Report
Short Interest ↓
Gap Down
HAO
Haoxi Health Technology
N/A$1.16
+0.9%
N/A-98.4%$1.50M$48.52M0.0029Gap Up

Related Companies and Tools


This page (NASDAQ:UK) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners